Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy and Safety of the Hcoil Deep TMS for the Treatment of Cannabis Addiction

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2007 by Shalvata Mental Health Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Shalvata Mental Health Center
ClinicalTrials.gov Identifier:
NCT00543036
First received: October 11, 2007
Last updated: NA
Last verified: August 2007
History: No changes posted

October 11, 2007
October 11, 2007
Not Provided
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Efficacy and Safety of the Hcoil Deep TMS for the Treatment of Cannabis Addiction
Not Provided

Evaluation of efficacy and safety of H-coil deep transcranial magnetic stimulation 9 week treatment trial for cannabis addiction as assessed by measures of drug intake and craving.

Not Provided
Interventional
Phase 1
Phase 2
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Treatment
Marijuana Abuse
Device: H-Coil deep TMS
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • Male and Female, aged 21-70 years, who meet DSM-IV TR diagnostic criteria for cannabis abuse and are motivated to quit cannabis use as assessed in the screening visit and gave their written informed consent to participate in the study.

Exclusion Criteria:

  • History of a primary major psychiatric other then cannabis abuse, or cognitive disorder according to DSM-IV TR criteria.
  • Hamilton depression scale rated 25 and above (moderate to severe depression)
  • Current alcohol or other substance abuse or dependence
  • Alcohol or other substance abuse or dependence during the last 12 months before recruitment.
  • History of or evidence of significant brain malformation,neoplasm, head injury, cerebral vascular events,neurodegenerative disorder or brain surgery.
  • Severe somatic co-morbidity
  • History of seizures Cardiac pace maker or other electronic implants Pregnancy and lactation
Both
21 Years to 70 Years
No
Contact: Ziv Carmel, M.D. +972-9-7478570 zivca@clalit.org.il
Israel
 
NCT00543036
SH 30107
Not Provided
Not Provided
Shalvata Mental Health Center
Not Provided
Principal Investigator: Ziv Carmel, M.D Shalvata MHC affiliated to Tel-Aviv universtiy, Sackler school of medicine
Principal Investigator: Abraham Zangen, Ph.D. Weizmann Institute, Rehovot, Israel
Shalvata Mental Health Center
August 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP